Tuesday, February 9, 2010
"Concise industry news from the US pharmaceutical industry..."
How will pharmacogenomics impact the industry's business models? Plus interviews with Nycomed CEO Håkan Björklund and EMD Serono CEO Fereydoun Firouz.
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP US
Editor NGP US
Sizing up the future
What role will individually tailored therapies play in the pharmaceutical industry’s new business models?01 Oct 2009
You need adobe flash player to view this content
Latest News
-
Who influenced WHO?
Is it better to overestimate the threat of a virus and spend millions on vaccines that may not be needed, or make a misjudgment in the other direction and cause millions of...Read more
02/04/2010 14:14
Comments -
Gates pledges $10 billion
At last week's World Economic Forum in Davos, Switzerland, revered business tycoon and founder of computer software giant Microsoft, Bill Gates, announced with his wife Melinda,...Read more
02/01/2010 16:31
Comments -
Malaria breakthrough
Scientists across the globe have long hunted for a vaccine against malaria - a disease that claims roughly one million lives each year. But last week, after decades of...Read more
01/25/2010 16:12
Comments -
Novartis: $2.5 million to Haiti victims
On 12 January, Haiti was rocked by the largest earthquake ever recorded in the area. The incident has sparked the call for emergency aid across the world, and now, thanks to...Read more
01/19/2010 13:16
Comments -
J&J sued for alleged kickbacks
Leading pharmaceutical firm Johnson & Johnson are reportedly the latest firm accused of paying kickbacks to the pharmaceutical supply chain. This time to boost sales of its...Read more
01/18/2010 13:52
Comments -
J&J recall numerous products
Pharmaceutical giant Johnson & Johnson is facing a new scandal as its consumer division said it was recalling more than 500 products that are available over-the-counter,...Read more
01/15/2010 16:35
Comments
Editor’s Choice
-
The pharmaceutical supply chain
Tightening the security of the pharmaceutical supply chain is becoming a key issue for the industry. The fight to avoid contaminated ingredients finding their way into medicines...Read more -
The growth of generic drug companies
As one door closes, another opens. And over the next few years, as drug patent expiries heat up, those that will profit most will be the generic drug companies, marking a new...Read more -
Drug patent problem rocks AstraZenenca
At the end of last week, the chief executive of AstraZeneca unveiled a 27 percent jump in pre-tax profits for the third quarter. But, with drug patents facing expiration -...Read more -
Faking It
Travis Johnson of International Anti-Counterfeiting Coalition talks to NGP about the global problem of counterfeit pharmaceuticals.Read more -
Adapt or Perish
A new report from A T Kearney’s highlights what the pharmaceutical industry must do to survive.Read more -
Gearing up for Battle
Novartis Vaccines’ CEO Andrin Oswald tells NGP how the company is preparing for the next wave of H1N1 mutations, and why a new manufacturing process is needed to provide faster...Read more
Readers’ Choice
-
Breaking New Ground
Sean Harper tells NGP why he is excited about potential new treatments for osteoporosis, why animal models aren't always useful in developing drugs for humans, and why the...Read more -
Customer Centric Service: The New Rx fo...
As the industry moves from its traditional sales and marketing approach to customer centric service models, companies are seeking to better meet physicians’ need for product,...Read more -
In with the New
When Chris Viehbacher arrived to take up the reins as CEO of sanofi-aventis, he found a company with an image problem that had forgotten how to communicate. Now he plans to...Read more -
Pharmaceutical Marketing After the Gold ...
Targeted Analytics Become Keys to a Lean, Mean Branding Machine By Mukesh Mehta, RPhRead more -
Early Phase Research – The Problem, the ...
Members of product development teams typically visit the Phase I-II world every few years. Increasingly, however, they are finding it a different world at each visit, due to a...Read more -
The Enterprise Lab Notebook
Enabling multi-disciplinary virtual teams to improve R&D productivity through knowledge sharing. By Symyx Technologies, Inc.Read more
Executive Interviews
Strengthening Sales Success
John Moran of IMS Management Consulting looks at how value delivered to offices can be used as a key metric of sales force performance.
Read more
Tools for Streamlining the Manufacturing Process
René Schwarz of Rockwell Automation tells NGP why manufacturing execution systems are important for achieving operational excellence.
Read more
Building Quality
Mary Jo Wojtusik of Waters explains the benefits of using a Quality by Design approach.
Read more
Next Generation Healthcare Summit 2010
11th - 13th May
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.